Use of a linear array for the detection of human papillomavirus genotypes in head and neck cancer

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 12, 2010, Pages 1813-1817

  Black, Candice C ^a   Bentley, Heather A ^a   Davis, Thomas H ^a   Tsongalis, Gregory J ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; DNA PROBE; EVALUATION; FEMALE; GENETICS; GENOTYPE; HEAD AND NECK TUMOR; HUMAN; LIMIT OF DETECTION; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MOLECULAR DIAGNOSIS; NUCLEIC ACID HYBRIDIZATION; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; POLYMERASE CHAIN REACTION; REPRODUCIBILITY; VIROLOGY;

ADULT; AGED; DNA PROBES, HPV; DNA, VIRAL; FEMALE; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; LIMIT OF DETECTION; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS;

EID: 78650452733     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94(2):153-156.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225-249.
3. Frisch M, Hjalgrim H, Jaeger AB, Bigger RJ. Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control. 2000;11(6):489-495.
4. Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U. S. population ages 20-44 years. Cancer. 2005(9); 103:1843-1849.
5. Franceschi S, Munoz N, Snijders PJ. How strong and how wide is the link between HPV and oropharyngeal cancer? Lancet. 2000:356 (9233):871-872.
6. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92(9):709-720.
7. Smith EM, Ritchie JM, Summersgill JF, et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst. 2004;96(6):449-455.
8. Klussmann JP, Mooren JJ, Lehen M, et al. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res. 2009;15(5):1779-1786.
9. Snijders PJ, Cromme FV, van den Brule AJ, et al. Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer. 1992;51(6):845-850.
10. Ryerson AB, Peters ES, Coughlin SS, et al. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer. 2008;113(10) (suppl): 2901-2909.
11. Dahlstrand H, Nasman A, Romanitan M, Lindquist D, Ramqvist T, Dalianis T. Human papillomavirus accounts both for increased incidence and better prognosis in tonsillar cancer. Anticancer Res. 2008;28(2 B): 1133-1138.
12. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008;100(6):407-420.
13. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944-1956.
14. D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis. 2009;199(9):1263-1269.
15. Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007;121(8):1813-1820.
16. Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol. 2009;27(12):1992-1998.
17. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100(4):261-269.
18. Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol. 2004;31(6):744-754.
19. Winn RJ, McClure JS. NCCN Clinical Practice Guidelines in Oncology Head and Neck Cancers: Cancer of the Oropharynx Web site. Version 1. 2009. National Comprehensive Cancer Network, Inc. http://www.nccn.org/professionals/physician- gls/f-guidelines.asp. Accessed August 14, 2009.